[go: up one dir, main page]

CU23397B7 - RESERVE MICROCAPPS FOR SLOW AND CONTROLLED RELEASE OF PERINDOPRIL. - Google Patents

RESERVE MICROCAPPS FOR SLOW AND CONTROLLED RELEASE OF PERINDOPRIL.

Info

Publication number
CU23397B7
CU23397B7 CU20040294A CU20040294A CU23397B7 CU 23397 B7 CU23397 B7 CU 23397B7 CU 20040294 A CU20040294 A CU 20040294A CU 20040294 A CU20040294 A CU 20040294A CU 23397 B7 CU23397 B7 CU 23397B7
Authority
CU
Cuba
Prior art keywords
controlled release
microcapps
perindopril
reserve
slow
Prior art date
Application number
CU20040294A
Other languages
Spanish (es)
Inventor
Remi Meyrueix
Catherine Castan
Valerie Legrand
Patrick Wutrich
Huet De Barochez Bruno
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Priority to CU20040294A priority Critical patent/CU23397B7/en
Publication of CU23397B7 publication Critical patent/CU23397B7/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

La presente invención se relaciona con cápsulas que permiten la liberación retardada y controlada del perindropil, o de una de sus sales farmacéuticamente aceptables, destinadas a una administración por vía oral.The present invention relates to capsules that allow the delayed and controlled release of perindropyl, or of a pharmaceutically acceptable salt thereof, intended for oral administration.

CU20040294A 2004-12-24 2004-12-24 RESERVE MICROCAPPS FOR SLOW AND CONTROLLED RELEASE OF PERINDOPRIL. CU23397B7 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CU20040294A CU23397B7 (en) 2004-12-24 2004-12-24 RESERVE MICROCAPPS FOR SLOW AND CONTROLLED RELEASE OF PERINDOPRIL.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20040294A CU23397B7 (en) 2004-12-24 2004-12-24 RESERVE MICROCAPPS FOR SLOW AND CONTROLLED RELEASE OF PERINDOPRIL.

Publications (1)

Publication Number Publication Date
CU23397B7 true CU23397B7 (en) 2009-07-16

Family

ID=40943382

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20040294A CU23397B7 (en) 2004-12-24 2004-12-24 RESERVE MICROCAPPS FOR SLOW AND CONTROLLED RELEASE OF PERINDOPRIL.

Country Status (1)

Country Link
CU (1) CU23397B7 (en)

Similar Documents

Publication Publication Date Title
CL2017003320A1 (en) Pharmaceutical formulations containing tenofovir and emtricitabine
MX2020013116A (en) Novel salts and crystals.
AR061446A1 (en) USE OF 1,7-DIMETHYLXANTINE FOR THE MANUFACTURE OF A NON-ANIOIOUS PSYCHOANALEPTIC DRUG FOR THE TREATMENT OF A NEUROPSYCHIATRIC DISORDER
GT200900283A (en) "COMBINATION THERAPY WITH A COMPOUND ACTING AS AN ADP PLAQUETARY RECEPTOR INHIBITOR".
AR065809A1 (en) PHARMACEUTICAL FORMULATIONS CONTAINING AN SGLT2 INHIBITOR
ECSP13012421A (en) PHARMACEUTICAL DOSAGE FORM INCLUDING 6'-FLUORO- (N-METHYL-ON, N-DIMETILE) -4-PHENYL-4 ', 9'-DIHIDRO-3'H-ESPIRO [CICLOHEXAN-1,1'-PIRANO [ 3,4, b] INDOL] -4-AMINA
ECSP13012424A (en) PHARMACEUTICAL DOSAGE AUCFORM INCLUDING 6'-FLUORO- (N-METHYL-ON, N-DIMETHYL) -4-PHENYL-4 ', 9'-DIHIDRO-3'H-ESPIRO [CICLOHEXAN-1,1'-PIRANO [ 3,4, b] INDOL] -4-AMINA
TW200833372A (en) Use of (meth)acrylate copolymers in delayed-release pharmaceutical forms for decreasing the influence of ethanol on the release of active compound
PA8809601A1 (en) ANTI-RETROVIRAL COMBINATION
ES2176106B1 (en) TRIMETAZIDINE PROLONGED MARRIAGE RELEASE COMPRESSED AFTER ORAL ADMINISTRATION.
CR9425A (en) ASSOCIATION BETWEEN RAILWAY AND AN ARTEMISININE DERIVATIVE FOR THE TREATMENT OF PALUDISM
CR9737A (en) DRUG DRUG ADMINISTRATION DEVICES CONTAINING O-DEMETILVENLAFAXIN (ODV) ITS SALTS.
CO6270217A2 (en) GALENIC FORMULATIONS OF ALISQUIRENO AND VALSARTAN
MX2010006204A (en) 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases.
CL2011000806A1 (en) Use of dabigatran etexilate or a salt thereof to prepare a useful medication for the prevention of stroke in patients suffering from atrial fibrillation.
CR20150266A (en) MODIFIED RELEASE FORMULATIONS FOR OPROZOMIB
CL2012001671A1 (en) Compounds derived from (methylsulfonyl) -ethyl-benzenoisoindoline; pharmaceutical composition that comprises them, use in the treatment of cancer, pain, CNS disorders, dermatological diseases, among others.
BR122016006880B8 (en) dosage form containing pantoprazole as active ingredient
AR049876A1 (en) PHARMACEUTICAL COMPOSITIONS TO TREAT SKIN DISEASES THAT INCLUDE A COMBINATION OF EPINASTINE AND ONE OR MORE ADDITIONAL MINERALS OR ONE OR MORE GROSS PHARMACOS
CR7648A (en) MICROCAPSULES FOR DELAYED AND CONTROLLED LIBERATION OF PERINDROPIL
CU23397B7 (en) RESERVE MICROCAPPS FOR SLOW AND CONTROLLED RELEASE OF PERINDOPRIL.
AR082560A1 (en) PHARMACEUTICAL DOSAGE FORM INCLUDING 6'-FLUORO- (N-METHYL-ON, N-DIMETILE) -4-PHENYL-4 ', 9'-DIHIDRO-3'H-ESPIRO [CICLOHEXAN-1,1'-PIRANO [ 3,4, B] INDOL] -4-AMINA
HN2010001775A (en) ORAL PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF A SALT OF KETEROLACO AND VITAMINS OF COMPLEX B
NO20043633L (en) Oral dosage form for controlled drug release
PA8805501A1 (en) USE OF MEQUITAZINE IN THE FORM OF A RACEMATE OR ENANTIOMER FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OR PREVENTION OF PATHOLOGIES THAT INVOLVE H4 HISTAMINAL RECEIVERS